Lumito AB engages in the development, manufacturing, and licensing of imaging products based on nanoparticles. It offers analysis instrument and reagents to the healthcare sector. The company was founded by Per Stefan Andersson-Engels on December 10, 2010 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company